Finland· FI-REL-REL56437

Ponvory

A ponesimod product containing ponesimod, registered in Finland by Laboratoires Juvise Pharmaceuticals. The same ATC class is registered in 11 of our 19 countries.

ATC L04AE04

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedPonvoryATCL04AE04REGISTER NO.FI-REL-REL56437PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Ponesimod is registered in 11 of 19 countries.

Countries holding a registration under ATC L04AE04 (ponesimod), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose

Ponesimod · ATC L04AE04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ponesimod costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ponesimod · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • IT Italy$69.77
  • CH Switzerland$69.06
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Ponesimod
Manufacturer
Laboratoires Juvise Pharmaceuticals
Country
Finland (FI)
ATC code
L04AE04
ATC class
Ponesimod
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9983900f-92fc-4d62-963c-d71e47c0a4fa
GET /v1/drugs/9983900f-92fc-4d62-963c-d71e47c0a4fa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "20",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "mg",
  "strength": "20 mg",
  "atc_label": "ponesimodi",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/21/1550/002-003",
  "fimea_rel_id": "REL56437",
  "authorised_at": "2021-05-19"
}

See everything about ponesimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.